$AGRI
AGRIFORCE GROWING SYSTEMS LTD. Stock $agri

$agri Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000149315224046821 Filed on November 19, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q4
Revenue			$16.28K
YoY Change
Cost Of Revenue			$13.58K
YoY Change
Gross Profit			$2.700K
YoY Change
Gross Profit Margin			16.58%
Selling, General & Admin		$305.5K	$3.631M
YoY Change		50.42%	15.82%
% of Gross Profit			134480.74%
Research & Development		$54.04K
YoY Change		-299.79%
% of Gross Profit
Depreciation & Amortization		$169.3K	$169.8K
YoY Change		-0.44%	2434.93%
% of Gross Profit			6290.37%
Operating Expenses		$5.605M	$3.789M
YoY Change		3084.47%	16.03%
Operating Profit		-$5.605M	-$3.786M
YoY Change		243.67%
Interest Expense		-$631.0K	-$1.994M
YoY Change		-69.81%	27.74%
% of Operating Profit
Other Income/Expense, Net		$314.0K	$2.469M
YoY Change		36.51%	19.01%
Pretax Income		-$5.847M	-$3.993M
YoY Change		67.55%	45.07%
Income Tax
% Of Pretax Income
Net Earnings		-$5.847M	-$3.993M
YoY Change		67.4%	45.07%
Net Earnings / Revenue			-24527.83%
Basic Earnings Per Share		-$0.06
Diluted Earnings Per Share		-$0.06	-$1.43
COMMON SHARES
Basic Shares Outstanding	155.0M shares	92.34M shares	1.414M shares
Diluted Shares Outstanding		92.02M shares

Balance Sheet

Concept	2024 Q3	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.373M	$3.879M
YoY Change	69.54%	70.91%
Cash & Equivalents	$1.373M	$3.879M
Short-Term Investments
Other Short-Term Assets	$74.94K	$272.9K
YoY Change	-70.02%	-54.4%
Inventory	$47.17K	$38.86K
Prepaid Expenses	$280.3K	$223.6K
Receivables	$163.00	$30.86K
Other Receivables	$23.65K	$0.00
Total Short-Term Assets	$1.944M	$4.221M
YoY Change	67.52%	44.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.612K	$125.4K
YoY Change	-97.18%	3.04%
Goodwill	$314.4K
YoY Change
Intangibles	$8.370M	$12.73M
YoY Change	-33.68%	-2.72%
Long-Term Investments		$223.8K
YoY Change
Other Assets	$48.21K	$63.71K
YoY Change		-96.95%
Total Long-Term Assets	$8.848M	$13.15M
YoY Change	-45.3%	-30.55%
TOTAL ASSETS
Total Short-Term Assets	$1.944M	$4.221M
Total Long-Term Assets	$8.848M	$13.15M
Total Assets	$10.79M	$17.37M
YoY Change	-37.75%	-20.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$612.1K	$1.074M
YoY Change	-1.89%	115.49%
Accrued Expenses	$962.5K	$868.5K
YoY Change	44.58%	137.59%
Deferred Revenue		$15.34K
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.094M	$4.085M
YoY Change	-76.58%	3.62%
Total Short-Term Liabilities	$3.160M	$6.042M
YoY Change	-53.94%	12.71%
LONG-TERM LIABILITIES
Long-Term Debt	$44.45K	$45.37K
YoY Change	11.13%	2.42%
Other Long-Term Liabilities	$25.17K	$2.716M
YoY Change	-99.18%	-53.96%
Total Long-Term Liabilities	$25.17K	$2.761M
YoY Change	-99.19%	-53.54%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.160M	$6.042M
Total Long-Term Liabilities	$25.17K	$2.761M
Total Liabilities	$4.122M	$8.803M
YoY Change	-58.72%	-22.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$57.91M	-$44.50M
YoY Change	42.95%	35.67%
Common Stock	$62.13M	$49.83M
YoY Change	48.31%	83.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.669M	$8.565M
YoY Change
Total Liabilities & Shareholders Equity	$10.79M	$17.37M
YoY Change	-37.75%	-20.5%

Cashflow Statement

Concept	2024 Q3	2023 Q4
OPERATING ACTIVITIES
Net Income	-$5.847M	-$3.993M
YoY Change	67.4%	45.07%
Depreciation, Depletion And Amortization	$169.3K	$169.8K
YoY Change	-0.44%	2434.93%
Cash From Operating Activities	-$1.201M	-$1.065M
YoY Change	9.15%	-66.62%
INVESTING ACTIVITIES
Capital Expenditures		$225.0K
YoY Change		-687.93%
Acquisitions
YoY Change
Other Investing Activities	-$356.1K	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$356.1K	-$225.0K
YoY Change		1243.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	4.534M
YoY Change	-100.0%	-300.66%
NET CHANGE
Cash From Operating Activities	-1.201M	-1.065M
Cash From Investing Activities	-356.1K	-225.0K
Cash From Financing Activities	0.000	4.534M
Net Change In Cash	-1.557M	3.244M
YoY Change	238.42%	-159.33%
FREE CASH FLOW
Cash From Operating Activities	-$1.201M	-$1.065M
Capital Expenditures		$225.0K
Free Cash Flow		-$1.290M
YoY Change		-59.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
	AGRI	Write Off Of Deposit WriteOffOfDeposit		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2024Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	486521	usd
CY2023Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	603242	usd
CY2023Q3	AGRI	Investor And Public Relations InvestorAndPublicRelations	61319	usd
	AGRI	Investor And Public Relations InvestorAndPublicRelations	104460	usd
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Entity Address Address Line1 EntityAddressAddressLine1	800 – 525 West 8th Avenue
	dei	Entity Address City Or Town EntityAddressCityOrTown	Vancouver
	dei	Entity Address State Or Province EntityAddressStateOrProvince	BC
	dei	Entity Address Country EntityAddressCountry	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	V5Z 1C6
	dei	City Area Code CityAreaCode	(604)
	dei	Local Phone Number LocalPhoneNumber	757-0952
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	23646	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	30859	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	499682	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	272872	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	38857	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	1943959	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4221166	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2612	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11801	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8370423	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12733885	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	47174	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001826397
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2024Q3	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets		usd
CY2023Q4	us-gaap	Asset Acquisition Contingent Consideration Liability Current AssetAcquisitionContingentConsiderationLiabilityCurrent		usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
CY2023Q4	us-gaap	Asset Acquisition Contingent Consideration Liability Noncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent		usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2024Q3	us-gaap	Gross Profit GrossProfit		usd
CY2023Q3	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Gross Profit GrossProfit		usd
CY2023Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	AGRI	Gain Loss On Extinguishment Of Warrant Liability GainLossOnExtinguishmentOfWarrantLiability		usd
	AGRI	Gain Loss On Extinguishment Of Warrant Liability GainLossOnExtinguishmentOfWarrantLiability		usd
CY2023Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2024Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		usd
CY2023Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense		usd
CY2024Q3	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023Q3	us-gaap	Inventory Write Down InventoryWriteDown		usd
	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2024Q3	AGRI	Write Off Of Deposit WriteOffOfDeposit		usd
CY2023Q3	AGRI	Write Off Of Deposit WriteOffOfDeposit		usd
	AGRI	Write Off Of Deposit WriteOffOfDeposit		usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation		usd
	AGRI	Stock Issued During Period Value Conversion Of Vested Prefunded Warrants StockIssuedDuringPeriodValueConversionOfVestedPrefundedWarrants		usd
CY2023Q3	AGRI	Stock Issued During Period Value Conversion Of Vested Prefunded Warrants StockIssuedDuringPeriodValueConversionOfVestedPrefundedWarrants		usd
	AGRI	Stock Issued During Period Value Conversion Of Vested Prefunded Warrants StockIssuedDuringPeriodValueConversionOfVestedPrefundedWarrants		usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	AGRI	Increase Decrease In Lease Deposit Asset IncreaseDecreaseInLeaseDepositAsset		usd
	AGRI	Increase Decrease In Rightofuse Asset IncreaseDecreaseInRightofuseAsset		usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
	AGRI	Payments To Acquire Note Payable PaymentsToAcquireNotePayable		usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	AGRI	Initial Fair Value Of Debenture Warrants Fifth Tranche Warrants InitialFairValueOfDebentureWarrantsFifthTrancheWarrants		usd
	AGRI	Initial Fair Value Of Conversion Feature Of Debentures Fifth Tranche Debentures InitialFairValueOfConversionFeatureOfDebenturesFifthTrancheDebentures		usd
	AGRI	Initial Fair Value Of Debenture Warrants Sixth Tranche Warrants InitialFairValueOfDebentureWarrantsSixthTrancheWarrants		usd
	AGRI	Initial Fair Value Of Conversion Feature Of Debentures Six Tranche Debentures InitialFairValueOfConversionFeatureOfDebenturesSixTrancheDebentures		usd
	AGRI	Initial Fair Value Of Debenture Warrants Seventh Tranche Warrants InitialFairValueOfDebentureWarrantsSeventhTrancheWarrants		usd
	AGRI	Initial Fair Value Of Conversion Feature Of Debentures Seventh Tranche Debentures InitialFairValueOfConversionFeatureOfDebenturesSeventhTrancheDebentures		usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid		usd
	AGRI	Forgiveness Of Note Payable In Business Combination ForgivenessOfNotePayableInBusinessCombination		usd
	AGRI	Initial Fair Value Of Contingent Consideration For Business Combination InitialFairValueOfContingentConsiderationForBusinessCombination		usd
	AGRI	Cancellation Of Investment Balance Due To Business Combination CancellationOfInvestmentBalanceDueToBusinessCombination		usd
	AGRI	Conversion Of Prefunded Warrants To Equity ConversionOfPrefundedWarrantsToEquity		usd
	AGRI	Shares Issued For Business Combination SharesIssuedForBusinessCombination		usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
	us-gaap	Revenues Revenues		usd
	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40578
	dei	Entity Registrant Name EntityRegistrantName	AGRIFORCE GROWING SYSTEMS LTD.
	dei	Security12b Title Security12bTitle	Common Shares
	dei	Trading Symbol TradingSymbol	AGRI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	155029573	shares
CY2024Q3	us-gaap	Cash Cash	1373294	usd
CY2023Q4	us-gaap	Cash Cash	3878578	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	163	usd
CY2024Q3	us-gaap	Goodwill Goodwill	314387	usd
CY2024Q3	AGRI	Lease Deposit Noncurrent Assets LeaseDepositNoncurrentAssets	48206	usd
CY2023Q4	AGRI	Lease Deposit Noncurrent Assets LeaseDepositNoncurrentAssets	63708	usd
CY2024Q3	AGRI	Construction In Progress ConstructionInProgress	112281	usd
CY2023Q4	AGRI	Construction In Progress ConstructionInProgress	113566	usd
CY2023Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	223801	usd
CY2024Q3	us-gaap	Assets Assets	10791868	usd
CY2023Q4	us-gaap	Assets Assets	17367927	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2024621	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1942011	usd
CY2024Q3	us-gaap	Secured Debt Current SecuredDebtCurrent	1093907	usd
CY2023Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	4084643	usd
CY2024Q3	us-gaap	Asset Acquisition Contingent Consideration Liability Current AssetAcquisitionContingentConsiderationLiabilityCurrent	41659	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	15336	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3160187	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6041990	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	25165	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	25684	usd
CY2024Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	854022	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2690308	usd
CY2024Q3	us-gaap	Asset Acquisition Contingent Consideration Liability Noncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent	38559	usd
CY2024Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	44448	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	45365	usd
CY2024Q3	us-gaap	Liabilities Liabilities	4122381	usd
CY2023Q4	us-gaap	Liabilities Liabilities	8803347	usd
CY2024Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99343334	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99343334	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5841045	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5841045	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	62130241	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	49828942	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2964795	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3472444	usd
CY2024Q3	AGRI	Obligation To Issue Shares ObligationToIssueShares	44214	usd
CY2023Q4	AGRI	Obligation To Issue Shares ObligationToIssueShares	97094	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-57914468	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44507304	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-555295	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-326596	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	6669487	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8564580	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10791868	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17367927	usd
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1:50 reverse stock split
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	41315	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	34192	usd
	us-gaap	Gross Profit GrossProfit	7123	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1205741	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2319026	usd
CY2024Q3	AGRI	Consulting Fees Or Expenses ConsultingFeesOrExpenses	177215	usd
CY2023Q3	AGRI	Consulting Fees Or Expenses ConsultingFeesOrExpenses	147190	usd
	AGRI	Consulting Fees Or Expenses ConsultingFeesOrExpenses	363411	usd
	AGRI	Consulting Fees Or Expenses ConsultingFeesOrExpenses	1032210	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	112361	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	277694	usd
	us-gaap	Professional Fees ProfessionalFees	442090	usd
	us-gaap	Professional Fees ProfessionalFees	1026044	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	285186	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	191829	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	864983	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	821358	usd
CY2024Q3	AGRI	Investor And Public Relations InvestorAndPublicRelations	61814	usd
	AGRI	Investor And Public Relations InvestorAndPublicRelations	451184	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	169248	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	172096	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	499187	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	512695	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	63552	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	80537	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	127674	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	565861	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20281	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11242	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	96107	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	173568	usd
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	782	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	73261	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	59358	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	222535	usd
CY2024Q3	AGRI	Travel And Entertainment TravelAndEntertainment	23757	usd
CY2023Q3	AGRI	Travel And Entertainment TravelAndEntertainment	3813	usd
	AGRI	Travel And Entertainment TravelAndEntertainment	31915	usd
	AGRI	Travel And Entertainment TravelAndEntertainment	104938	usd
CY2024Q3	AGRI	Shareholder And Regulatory ShareholderAndRegulatory	13431	usd
CY2023Q3	AGRI	Shareholder And Regulatory ShareholderAndRegulatory	35857	usd
	AGRI	Shareholder And Regulatory ShareholderAndRegulatory	98880	usd
	AGRI	Shareholder And Regulatory ShareholderAndRegulatory	114674	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	54036	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	-27046	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	58130	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22312	usd
CY2024Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4137271	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4137271	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	5605455	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1631034	usd
	us-gaap	Operating Expenses OperatingExpenses	8089207	usd
	us-gaap	Operating Expenses OperatingExpenses	7366405	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5605455	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1631034	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8082084	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7366405	usd
CY2024Q3	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	469684	usd
CY2023Q3	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	2064936	usd
	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	2672765	usd
	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	6045214	usd
CY2024Q3	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-235376	usd
CY2023Q3	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-108125	usd
	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-1627858	usd
	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-541730	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	75119	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2223250	usd
CY2024Q3	AGRI	Gain Loss On Extinguishment Of Warrant Liability GainLossOnExtinguishmentOfWarrantLiability	14769	usd
	AGRI	Gain Loss On Extinguishment Of Warrant Liability GainLossOnExtinguishmentOfWarrantLiability	14769	usd
CY2024Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	505628	usd
CY2023Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	326042	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1198554	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	6159067	usd
CY2024Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-97488	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-97488	usd
CY2024Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-63834	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-25472	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	22918	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1317	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	4252	usd
	us-gaap	Inventory Write Down InventoryWriteDown	38470	usd
	AGRI	Write Off Of Deposit WriteOffOfDeposit	12000	usd
CY2024Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	28956	usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	10472	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	102762	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	64887	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-5847365	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3493053	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13407164	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7740078	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	179950	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-226286	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-228699	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	84719	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5667415	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3719339	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13635863	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7655359	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.03
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.58
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.58
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92015605	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	92015605	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	867110	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	867110	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50333281	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50333281	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	615152	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	615152	shares
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1:50 reverse stock split
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	11322990	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	708000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	295000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	10912	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-5847365	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	179950	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	6669487	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8564580	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	11332607	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	62759	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	27624	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	295000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	22780	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13407164	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-228699	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	6669487	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	7309236	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3013171	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	152055	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	640096	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	27150	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	-72056	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3493053	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-226286	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	7350313	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	10542653	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	10542653	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	4756872	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	355404	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	939695	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	204880	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	80885	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-2085960	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	211243	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7740078	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	84719	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	7350313	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	7350313	usd
CY2023Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1:50 reverse stock split
	us-gaap	Net Income Loss NetIncomeLoss	-13407164	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7740078	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	499187	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	512695	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4137271	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	22780	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	211243	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	27624	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	80885	usd
	AGRI	Shares Issued For Compensation SharesIssuedForCompensation	62759	usd
	AGRI	Shares Issued For Compensation SharesIssuedForCompensation	355404	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2619362	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5873396	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1198554	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	6159067	usd
	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-1627858	usd
	AGRI	Gain Loss On Conversion Of Convertible Debt GainLossOnConversionOfConvertibleDebt	-541730	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2223250	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-4252	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-97488	usd
	AGRI	Write Off Of Deposit WriteOffOfDeposit	12000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	164	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-7213	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	25794	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	226810	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-344309	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8317	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	38167	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	225000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	82610	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	783725	usd
	AGRI	Increase Decrease In Lease Deposit Asset IncreaseDecreaseInLeaseDepositAsset	-15502	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-15336	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	23333	usd
	AGRI	Increase Decrease In Rightofuse Asset IncreaseDecreaseInRightofuseAsset	134688	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-122894	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3429189	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5437592	usd
	AGRI	Payments To Acquire Note Payable PaymentsToAcquireNotePayable	202093	usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	153986	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-356079	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1342915	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	153220	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2250000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	4615385	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	802282	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1741950	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	84463	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	325962	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1363255	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3737168	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	-83271	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	17669	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2505284	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1682755	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3878578	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2269320	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1373294	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	586565	usd
	us-gaap	Interest Paid Net InterestPaidNet	53403	usd
	us-gaap	Interest Paid Net InterestPaidNet	171818	usd
	AGRI	Initial Fair Value Of Debenture Warrants Fifth Tranche Warrants InitialFairValueOfDebentureWarrantsFifthTrancheWarrants	564000	usd
	AGRI	Initial Fair Value Of Conversion Feature Of Debentures Fifth Tranche Debentures InitialFairValueOfConversionFeatureOfDebenturesFifthTrancheDebentures	359000	usd
	AGRI	Initial Fair Value Of Debenture Warrants Sixth Tranche Warrants InitialFairValueOfDebentureWarrantsSixthTrancheWarrants	242000	usd
	AGRI	Initial Fair Value Of Conversion Feature Of Debentures Six Tranche Debentures InitialFairValueOfConversionFeatureOfDebenturesSixTrancheDebentures	198000	usd
	AGRI	Initial Fair Value Of Debenture Warrants Seventh Tranche Warrants InitialFairValueOfDebentureWarrantsSeventhTrancheWarrants	369000	usd
	AGRI	Initial Fair Value Of Conversion Feature Of Debentures Seventh Tranche Debentures InitialFairValueOfConversionFeatureOfDebenturesSeventhTrancheDebentures	297000	usd
	AGRI	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	11322607	usd
	AGRI	Shares Issued For Conversion Of Convertible Debt SharesIssuedForConversionOfConvertibleDebt	4756872	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	39875	usd
	AGRI	Forgiveness Of Note Payable In Business Combination ForgivenessOfNotePayableInBusinessCombination	202093	usd
	AGRI	Initial Fair Value Of Contingent Consideration For Business Combination InitialFairValueOfContingentConsiderationForBusinessCombination	79000	usd
	AGRI	Cancellation Of Investment Balance Due To Business Combination CancellationOfInvestmentBalanceDueToBusinessCombination	118850	usd
	AGRI	Conversion Of Prefunded Warrants To Equity ConversionOfPrefundedWarrantsToEquity	530429	usd
	AGRI	Shares Issued For Business Combination SharesIssuedForBusinessCombination	295000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80D_eus-gaap--NatureOfOperations_zpBy5O2wW7Ik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_822_zE8CPdrGISw6">NATURE OF OPERATIONS AND BASIS OF PREPARATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business Overview</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AgriFORCE Growing Systems Ltd. (“AgriFORCE™” or the “Company”) was incorporated as a private company by Articles of Incorporation issued pursuant to the provisions of the <i>Business Corporations Act (British Columbia)</i> on December 22, 2017. The Company’s registered and records office address is at 800 – 525 West 8<sup>th</sup> Avenue, Vancouver, British Columbia, Canada, V5Z 1C6.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is an innovative sustainable technology focused company that strives to innovate and deliver sustainable technology solutions across a wide array of verticals utilization of our proprietary intellectual property to businesses and enterprises through our AgriFORCE™ Solutions division (“Solutions”) and deliver innovative flour products through our AgriFORCE™ Brands division (“Brands”). In the third quarter of 2024, the Company bought the assets of the Radical Clean Solutions (“RCS”) business for which it had bought an exclusive license to the agricultural industry in 2023. During 2023, the Company commenced efforts to launch its UN(THINK) Awakened Flour™, which is a nutritious flour that we believe provides health advantages over traditional flour.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While Solutions’ legacy focus was to operate in the plant based pharmaceutical, nutraceutical, and other high value crop markets using its unique proprietary facility design and hydroponics based automated growing system that enable cultivators to effectively grow crops in a controlled environment (“FORCEGH+™”). it has changed its focus to broaden the use of its proprietary intellectual property across multiple industries. For instance, the Company through its RCS purchase is not able to utilize that technology to deliver solutions across multiple industries, including not only agriculture, but other industries including hospitality, commercial applications, education institutions, residential real estate and transportation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brands is focused on the development and commercialization of plant-based ingredients and products that deliver healthier and more nutritious solutions. We strive to market and commercialize both branded consumer product offerings and ingredient supply.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis of Presentation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying Unaudited Condensed Consolidated Interim Financial Statements and related financial information of AgriFORCE Growing Systems Ltd. should be read in conjunction with the audited financial statements and the related notes thereto for the years ended December 31, 2023 and 2022 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on April 1, 2024. These unaudited interim financial statements have been prepared in accordance with the rules and regulations of the United States Securities and SEC for interim financial information. Accordingly, they do not include all of the information and footnotes required by the accounting principles generally accepted in the United States of America (“U.S. GAAP”) for complete financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the opinion of management, the accompanying interim financial statements contain all adjustments which are necessary to state fairly the Company’s financial position as of September 30, 2024 and December 31, 2023, and the results of its operations and cash flows during the nine months ended September 30, 2024 and 2023. Such adjustments are of a normal and recurring nature. The results for the nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2024, or for any future period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity and Management’s Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has incurred substantial operating losses since its inception and expects to continue to incur significant operating losses for the foreseeable future. As reflected in the interim financial statements for the nine months ended September 30, 2024, the Company had a net loss of $<span id="xdx_900_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20240101__20240930_zF4bbMqmsmfg">13.4</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, $<span id="xdx_90E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn5n6_di_c20240101__20240930_zYiVlI8xEZnl">3.4</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of net cash used in operating activities, and the Company had a working capital deficiency of $<span id="xdx_903_ecustom--WorkingCapitalDeficit_iNI_pn5n6_di_c20240930_zZ0FR5WnylGh" title="Working capital deficit">1.2</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 24, 2024, the Company received a Staff Listing Determination Letter from Nasdaq pursuant to which the Staff has determined that as of June 21, 2024, the Company’s common shares had a per share closing bid price of $<span id="xdx_904_ecustom--CommonStockClosingBidPrice_c20240606__20240621_z9aO6llPcB6d" title="Closing bid price">0.10</span> or less for ten consecutive trading days (the Company’s bid price has closed at or below $<span id="xdx_902_ecustom--CommonStockClosingBidPrice_c20240606__20240621_zUhI9SzeBBhk" title="Closing bid price">0.10</span> per share from June 6, 2024, through June 21, 2024). Nasdaq has granted the Company an exception to comply with the bid price rule as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On or before November 27, 2024, the Company shall obtain shareholders approval for a reverse stock split at a ratio that satisfies the minimum requirement in the Bid Price Rule;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On or before December 4, 2024, the Company shall effect a reverse stock split and, thereafter, maintain a $<span id="xdx_900_ecustom--CommonStockClosingBidPrice_pid_c20241204__20241204__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1NGR8Vfglhc" title="Closing bid price">1</span> closing bid price for a minimum of ten consecutive business days;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On or before December 17, 2024, the Company shall have demonstrated compliance with the Bid Price Rule, by evidencing a closing bid price of $<span id="xdx_904_ecustom--CommonStockClosingBidPrice_pid_c20241217__20241217__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4DFK2yNkRBa" title="Closing bid price">1</span> or more per share for a minimum of ten consecutive trading sessions.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To meet these requirements, the Company is holding its previously postponed Annual Meeting of Shareholders on November 25, 2024, and assuming shareholder approval, will effect a reverse split immediately thereafter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying interim financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The interim financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty. The Company is at the development stage of its business plan. As such it is likely that additional financing will be needed by the Company to fund its operations and to develop and commercialize its technology. These factors raise substantial doubt about the Company’s ability to continue as a going concern. For the next twelve months from issuance of these interim financial statements, the Company plans to seek to obtain additional capital through the sale of debt or equity financings or other arrangements to fund operations; however, there can be no assurance that the Company will be able to raise needed capital under acceptable terms, if at all. The sale of additional equity may dilute existing shareholders and newly issued shares may contain senior rights and preferences compared to our currently outstanding common shares. If the Company is unable to obtain such additional financing, future operations would need to be scaled back or discontinued. Due to the uncertainty in the Company’s ability to raise capital, management believes that there is substantial doubt in the Company’s ability to continue as a going concern for twelve months from the issuance of these interim financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reverse Stock Split</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 11, 2023, the Company executed a one-for-fifty reverse stock split of the Company’s common shares (the “Reverse Split”). As a result of the Reverse Split, every 50 shares of the Company’s old common shares were converted into one share of the Company’s new common shares. Fractional shares resulting from the reverse split were rounded up to the nearest whole number. The Reverse Split automatically and proportionately adjusted all issued and outstanding shares of the Company’s common shares, as well as convertible debentures, convertible features, prefunded warrants, stock options and warrants outstanding at the time of the date of the Reverse Split. The exercise price on outstanding equity based-grants was proportionately increased, while the number of shares available under the Company’s equity-based plans was proportionately reduced. Share and per share data (except par value) for the periods presented reflect the effects of the Reverse Split. References to numbers of common shares and per share data in the accompanying financial statements and notes thereto for periods ended prior to October 11, 2023 have been adjusted to reflect the Reverse Split on a retroactive basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Net Income Loss NetIncomeLoss	-13400000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3400000	usd
CY2024Q3	AGRI	Working Capital Deficit WorkingCapitalDeficit	-1200000	usd
CY2024Q2	AGRI	Common Stock Closing Bid Price CommonStockClosingBidPrice	0.10
CY2024Q2	AGRI	Common Stock Closing Bid Price CommonStockClosingBidPrice	0.10
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zUuKbLiHNKVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zpWyEH2Vt0I6">Reclassifications</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has reclassified certain share base payment expenses from <i>Wages and salaries</i> to <i>Share based compensation</i> in the 2023 consolidated statements of comprehensive loss to align with the 2024 presentation.</span></p>
CY2024Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-97488	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-97488	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	41315	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	262991	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	13407164	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	11740635	usd
CY2024Q3	AGRI	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Note Payable Forgiven BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotePayableForgiven	202093	usd
CY2024Q3	AGRI	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Convertible Debentures Repaid BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConvertibleDebenturesRepaid	153986	usd
CY2024Q3	AGRI	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Common Shares BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCommonShares	295000	usd
CY2024Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Contingent Liability BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability	79000	usd
CY2024Q3	AGRI	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Previously Invested Equity BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPreviouslyInvestedEquity	118850	usd
CY2024Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	848929	usd
CY2024Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	848929	usd
CY2024Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	538000	usd
CY2024Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	310929	usd
CY2024Q3	AGRI	Legal Retainer LegalRetainer	31986	usd
CY2023Q4	AGRI	Legal Retainer LegalRetainer	8039	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	280291	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	223624	usd
CY2024Q3	AGRI	Inventory Advances InventoryAdvances	112463	usd
CY2023Q4	AGRI	Inventory Advances InventoryAdvances	30654	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	74942	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	10555	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	499682	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	272872	usd
	AGRI	Write Off Of Deposit WriteOffOfDeposit	12000	usd
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	47174	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	38857	usd
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	141175	shares
CY2024Q3	AGRI	Unconverted Prefunded Warrants Outstanding UnconvertedPrefundedWarrantsOutstanding	6425	shares
CY2023Q4	AGRI	Unconverted Prefunded Warrants Outstanding UnconvertedPrefundedWarrantsOutstanding	6425	shares
CY2024Q3	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P20Y
CY2024Q3	us-gaap	Finite Lived Intangible Assets Fair Value Disclosure FiniteLivedIntangibleAssetsFairValueDisclosure	7832200	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4137271	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	159312	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	656174	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	656174	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	656174	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	656174	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	639643	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	4946772	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8370423	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	612070	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	578128	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	962496	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	868451	usd
CY2024Q3	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	450055	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	495432	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2024621	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1942011	usd
CY2023Q3	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	5	integer
	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	The First, Second, Third, Fourth, Fifth, Sixth and Seventh Tranche Debentures (the “Debentures”) have an interest rate of 5% for the first 12 months, 6% for the subsequent 12 months, and 8% per annum thereafter. Principal repayments will be made in 25 equal installments which began on September 1, 2022 for the First Tranche Debentures, July 1, 2023 for the Second Tranche Debentures, January 1, 2024 for the Third Tranche Debentures, May 1, 2024 for the Fourth Tranche Debentures, August 1, 2024 for the Fifth Tranche Debentures, October 1, 2024 for the Sixth Tranche Debentures and November 1, 2024 for the Seventh Tranche Debentures. The Debentures may be extended by nine months at the election of the Company by paying a sum equal to nine months’ interest on the principal amount outstanding at the end of the 18th month, at the rate of 8% per annum.
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1104593	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	7385494	usd
CY2024Q3	us-gaap	Secured Debt Current SecuredDebtCurrent	1093907	usd
CY2023Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	4084643	usd
	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	2672765	usd
	AGRI	Accretion Interest On Debentures AccretionInterestOnDebentures	6045214	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	802282	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1741950	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	15336	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2690308	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	2029000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-2572123	usd
	AGRI	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Expires FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExpires	-14769	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-1198555	usd
	AGRI	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Effect Of Exchange Rate Changes FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodEffectOfExchangeRateChanges	-79839	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	854022	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4649115	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4649115	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	4022120	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-529340	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-6159067	usd
	AGRI	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Effect Of Exchange Rate Changes FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodEffectOfExchangeRateChanges	-24260	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1958568	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1958568	usd
CY2024Q2	us-gaap	Employee Stock Ownership Plan Esop Terms Of Repurchase Obligation EmployeeStockOwnershipPlanESOPTermsOfRepurchaseObligation	the Company’s Board of Directors authorized a share repurchase program (the “Repurchase Program”) under which the Company may repurchase up to $1 million of its outstanding common shares, for a period of six months, subject to contractual requirements.
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	36713491	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2367337	shares
	us-gaap	Revenues Revenues	41315	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	219018	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	59358	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3517	usd
	us-gaap	Lease Cost LeaseCost	59358	usd
	us-gaap	Lease Cost LeaseCost	222535	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	798000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1400500	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	2198500	usd
CY2023Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	451684	usd
CY2023Q3	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	230000	usd
CY2024Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	467249

Files In Submission

Name	View Source	Status
agri-20240930_cal.xml	Edgar Link	unprocessable
0001493152-24-046821-index-headers.html	Edgar Link	pending
0001493152-24-046821-index.html	Edgar Link	pending
0001493152-24-046821.txt	Edgar Link	pending
0001493152-24-046821-xbrl.zip	Edgar Link	pending
agri-20240930.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
form10-q_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
agri-20240930_def.xml	Edgar Link	unprocessable
agri-20240930_lab.xml	Edgar Link	unprocessable
agri-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AGRI
AGRIFORCE GROWING SYSTEMS LTD. Stock $agri

2024 Q4 Form 10-Q Financial Statement

#000149315224046821 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AGRI AGRIFORCE GROWING SYSTEMS LTD. Stock $agri

2024 Q4 Form 10-Q Financial Statement

#000149315224046821 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AGRI
AGRIFORCE GROWING SYSTEMS LTD. Stock $agri